Inovio Pharmaceuticals Inc (NAS:INO)
$ 4.19 0.18 (4.49%) Market Cap: 109.36 Mil Enterprise Value: 37.00 Mil PE Ratio: 0 PB Ratio: 1.48 GF Score: 46/100

Q2 2019 Inovio Pharmaceuticals Inc Earnings Call Transcript

Aug 08, 2019 / 08:30PM GMT
Release Date Price: $30.48 (+0.40%)
Operator

Good day, and welcome to the Inovio Second Quarter 2019 Financial Results Conference Call. (Operator Instructions) Please note this event is being recorded.

I would now like to turn the conference over to Ben Matone, Director of Investor Relations. Please go ahead.

Ben Matone
Inovio Pharmaceuticals, Inc. - Director of IR

Thank you, operator. Good afternoon, and welcome to the Inovio Pharmaceuticals Second Quarter 2019 Investor Conference Call. With me today are Inovio's President and CEO, Dr. J. Joseph Kim; and our Chief Financial Officer, Peter Kies.

Today's call is being webcast live, and a replay of today's call will be made available on our website, ir.inovio.com. Following a general business update, we will conduct a question-and-answer segment which will be reserved for equity research analysts. During the call, we will be making certain forward-looking statements that relate to our business, which include our plans to develop our immunotherapy platform in combination with our proprietary delivery devices as well as developments and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot